Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
Nov. 30, 2015
Nov. 30, 2014
Current Assets    
Cash and cash equivalents $ 4,152,162 $ 3,279,267
Restricted cash 204,344 204,141
Marketable securities 610,424 102,674
Accounts receivable (net of allowance for doubtful accounts of $2,067,130 and $1,976,966, respectively) 3,058,379 4,071,997
Deferred tax assets, current portion 1,336,000  
Prepaid expenses 427,819 710,754
Inventory, net 475,608 63,742
Other current assets 88,392 59,384
Total current assets 10,353,128 8,491,959
Property and Equipment-net 879,070 953,415
Other Assets    
Investment in Saneron CCEL Therapeutics, Inc.   684,000
Intangible assets, net 516,328 28,358
Goodwill 1,777,822 0
Deferred tax assets, net of current portion 5,930,987  
Deposits and other assets, net 40,611 51,854
Total other assets 8,265,748 764,212
Total assets 19,497,946 10,209,586
Current Liabilities    
Accounts payable 1,328,619 992,910
Accrued expenses 2,005,351 1,471,699
Current portion of note payable 307,420  
Deferred revenue 6,782,562 6,662,552
Total current liabilities 10,423,952 9,127,161
Other Liabilities    
Deferred revenue, net of current portion 10,869,218 9,509,088
Note payable, net of current portion 868,947  
Long-term liability - revenue sharing agreements 2,300,000 2,300,000
Total other liabilities $ 14,038,165 $ 11,809,088
Commitments and contingencies (Note 15)
Stockholders' Deficit    
Preferred stock
Common stock ($.01 par value, 20,000,000 authorized; 12,260,340 issued and 9,010,322 outstanding as of November 30, 2015 and 11,921,285 issued and 9,706,174 outstanding as of November 30, 2014) $ 122,603 $ 119,213
Additional paid-in capital 28,530,368 27,842,106
Treasury stock, at cost (8,318,083) (5,112,648)
Accumulated other comprehensive income 169,932  
Accumulated deficit (25,468,991) (33,575,334)
Total stockholders' deficit (4,964,171) (10,726,663)
Total liabilities and stockholders' deficit $ 19,497,946 $ 10,209,586
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock